Your browser doesn't support javascript.
loading
Incidence and Mortality of Uveal Melanoma in Hungary: A Nationwide Study.
Tóth, Gábor; Muzsik, Béla; Szajkó, Attila; Kerber, Pál; Dinya, Elek; Csákány, Béla; Nagy, Zoltán Zsolt; Németh, János.
Afiliação
  • Tóth G; Department of Ophthalmology, Semmelweis University, Mária utca 39, H-1085 Budapest, Hungary.
  • Muzsik B; National Directorate General for Hospitals, Diós árok 3, H-1125 Budapest, Hungary.
  • Szajkó A; National Directorate General for Hospitals, Diós árok 3, H-1125 Budapest, Hungary.
  • Kerber P; National Directorate General for Hospitals, Diós árok 3, H-1125 Budapest, Hungary.
  • Dinya E; Institute of Digital Health Sciences, Semmelweis University, Ferenc tér 15, H-1094 Budapest, Hungary.
  • Csákány B; Department of Ophthalmology, Semmelweis University, Mária utca 39, H-1085 Budapest, Hungary.
  • Nagy ZZ; Department of Ophthalmology, Semmelweis University, Mária utca 39, H-1085 Budapest, Hungary.
  • Németh J; Department of Ophthalmology, Semmelweis University, Mária utca 39, H-1085 Budapest, Hungary.
Cancers (Basel) ; 16(5)2024 Feb 25.
Article em En | MEDLINE | ID: mdl-38473294
ABSTRACT
Uveal melanoma (UM) is the most common primary malignant ocular tumour in adults, although its epidemiology in Central and Eastern Europe is unclear. This study aimed to analyse the incidence and all-cause mortality of UM in Hungary. This nationwide, retrospective, longitudinal study used data from the National Health Insurance Fund and included patients aged ≥18 years who were newly diagnosed with UM (ICD-10 C69.3 or C69.4) between 1 January 2012 and 31 December 2021. Age-standardised incidence and all-cause mortality rates were calculated using European Standard Population data from 2013. We identified 88 and 70 new patients with UM in 2012 and 2021, respectively, showing an almost stable trend. Age-standardised incidence rates varied between 6.40 and 10.96/1,000,000 person-years (PYs) during the analysed period. The highest age-standardised incidence was detected among men (13.38/1,000,000 PYs) in 2015. All-cause mortality decreased from 4.72/1,000,000 PYs to 0.79/1,000,000 PYs between 2012 and 2021. In conclusion, the UM incidence rate in Hungary is comparable to European incidence rates. The incidence did not markedly change, whereas all-cause mortality decreased during the study period, but this decline could not be attributed to improved treatment modalities for primary tumours and metastatic UM.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article